An In-Depth Approach to the Associations between MicroRNAs and Viral Load in Patients with Chronic Hepatitis B—A Systematic Review and Meta-Analysis
-
Published:2024-08-01
Issue:15
Volume:25
Page:8410
-
ISSN:1422-0067
-
Container-title:International Journal of Molecular Sciences
-
language:en
-
Short-container-title:IJMS
Author:
Manea Marina1ORCID, Mărunțelu Ion12ORCID, Constantinescu Ileana12ORCID
Affiliation:
1. Immunology and Transplant Immunology, University of Medicine and Pharmacy “Carol Davila”, 020021 Bucharest, Romania 2. Centre of Immunogenetics and Virology, Fundeni Clinical Institute, 022328 Bucharest, Romania
Abstract
Scientists study the molecular activities of the hepatitis B virus (HBV). However, in vivo experiments are scarce. Some microRNAs are HBV-related, but their exact mechanisms are unknown. Our study provides an up-to-date view of the associations between microRNAs and HBV-DNA levels in chronically infected individuals. We conducted this large-scale research on five databases according to PRISMA guidance. Joanna Briggs Institute tools and Newcastle Ottawa Quality Assessment scores helped with quality evaluations. R 4.2.2 performed statistical computations for the meta-analysis. DIANA-microT 2023 and g:Profiler enriched the predictions of liver genes associated with miR-122 and miR-192-5p. From the 1313 records, we eliminated those irrelevant to our theme, non-article methodologies, non-English entries, and duplicates. We assessed associations between microRNAs and HBV-DNA levels. Overall, the pooled correlations favoured the general idea of the connection between non-coding molecules and viremia levels. MiR-122 and miR-192-5p were the most researched microRNAs, significantly associated with HBV-DNA levels. The connections between miR-122, miR-192-5p, let-7, miR-215, miR-320, and viral loads need further in vivo assessment. To conclude, this study evaluates systematically, for the first time, the correlations between non-coding molecules and viremia levels in patients. Our meta-analysis emphasizes potentially important pathways toward new inhibitors of the viral replication cycle.
Reference100 articles.
1. European Centre for Disease Prevention and Control (2024, May 31). Prevention of Hepatitis B and C in the EU/EEA, Available online: https://data.europa.eu/doi/10.2900/703244. 2. Hepatitis, B. (2024, May 30). Surveillance Guidance, Available online: https://www.cdc.gov/hepatitis/statistics/SurveillanceGuidance/HepatitisB.htm. 3. Hepatitis, B. (2024, May 30). Available online: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b. 4. Torimiro, J.N.E., Duri, K., Goumkwa, N.M., Atah, S.M., Ondigui, J.-L.N., Lobe, C., Bouyou, M., Ndeboko, B., Moussa, A.M., and Police, C. (2024). Toward the elimination of hepatitis B: Networking to promote the prevention of vertical transmission of hepatitis B virus through population-based interventions and multidisciplinary groups in Africa. Front. Public Health, 12. 5. Nasrallah, G.K., Chemaitelly, H., Nizamuddin, P.B., Al-Sadeq, D.W., Shurrab, F.M., Amanullah, F.H., Al-Hamad, T.H., Mohammad, K.N., Alabdulmalek, M.A., and Al Kahlout, R.A. (2024). Prevalence of hepatitis B and C viruses among migrant workers in Qatar. Sci. Rep., 14.
|
|